Felix Hehnen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Felix Hehnen has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Michael Lommel
Institute of Computer-Assisted Cardiovascular Medicine, Deutsches Herzzentrum der Charit, CharitUniversittsmedizin Berlin, Berlin, Germany
3 shared publications - Christian Oliver Paschereit
TU Berlin
2 shared publications - Isabell Schulz
Institute of Computer-assisted Cardiovascular Medicine, Deutsches Herzzentrum der Charité, Augustenburger Platz 1, 13353 Berlin, Germany; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt - Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany
2 shared publications - Paul Friedrich Geus
Deutsches Herzzentrum der Charité, Institute of Computer-Assisted Cardiovascular Medicine, Augustenburger Platz 1, 13353 Berlin, Germany
2 shared publications - Sophia Krakowski
Biofluid Mechanics Laboratory, Institute of Computer-assisted Cardiovascular Medicine, Deutsches Herzzentrum der Charité, Germany
2 shared publications - Stefan Moritz
Section of Clinical Infectious Diseases, University Hospital Halle, Halle, Germany
2 shared publications
Latest Publications
- Open Access
- 26 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (15) , 1876
A Novel CTC-Binding Probe: Enzymatic vs. Shear Stress-Based Detachment Approaches
Background/Objectives: Liquid biopsy is a minimally invasive alternative to tissue biopsy and is used to obtain information about a disease from a blood sample or other body fluids. In the context of cancer, circulating tumor cells (CTC) can be used as biomarkers to determine the nature of the tumor, its stage of progression, and the efficiency of the administered therapy through monitoring. However, the low concentration of CTCs in blood (1–10 cells/mL) is a challenge for their isolation. Therefore, a minimally invasive medical device (BMProbe™) was developed that isolates CTCs via antigen–antibody binding directly from the bloodstream. Current investigations focus on the process of detaching bound cells from the BMProbe™ surface for cell cultivation and subsequent drug testing to enable personalized therapy planning. Methods: This article presents two approaches for detaching LNCaP cells from anti-EpCAM coated BMProbes™: enzymatic detachment using TrypLE™ and detachment through enzymatic pretreatment with supplementary flow-induced shear stress. The additional shear stress is intended to increase the detachment efficiency. To determine the flow rate required to gently detach the cells, a computational fluid dynamics (CFD) simulation was carried out. Results: The experimental test results demonstrate that 91% of the bound cells can be detached enzymatically within 10 min. Based on the simulation, a maximum flow rate of 47.76 mL/min was defined in the flow detachment system, causing an average shear stress of 8.4 Pa at the probe edges. The additional flow treatment did not increase the CTC detachment efficiency. Conclusions: It is feasible that the detachment efficiency can be further increased by a longer enzymatic incubation time or higher shear stress. The influence on the integrity and viability of cells must, however, be considered.
- 26 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (15) , 1876
Open AccessA Novel CTC-Binding Probe: Enzymatic vs. Shear Stress-Based Detachment Approaches
Background/Objectives: Liquid biopsy is a minimally invasive alternative to tissue biopsy and is used to obtain information about a disease from a blood sample or other body fluids. In the context of cancer, circulating tumor cells (CTC) can be used as biomarkers to determine the nature of the tumor, its stage of progression, and the efficiency of the administered therapy through monitoring. However, the low concentration of CTCs in blood (1–10 cells/mL) is a challenge for their isolation. Therefore, a minimally invasive medical device (BMProbe™) was developed that isolates CTCs via antigen–antibody binding directly from the bloodstream. Current investigations focus on the process of detaching bound cells from the BMProbe™ surface for cell cultivation and subsequent drug testing to enable personalized therapy planning. Methods: This article presents two approaches for detaching LNCaP cells from anti-EpCAM coated BMProbes™: enzymatic detachment using TrypLE™ and detachment through enzymatic pretreatment with supplementary flow-induced shear stress. The additional shear stress is intended to increase the detachment efficiency. To determine the flow rate required to gently detach the cells, a computational fluid dynamics (CFD) simulation was carried out. Results: The experimental test results demonstrate that 91% of the bound cells can be detached enzymatically within 10 min. Based on the simulation, a maximum flow rate of 47.76 mL/min was defined in the flow detachment system, causing an average shear stress of 8.4 Pa at the probe edges. The additional flow treatment did not increase the CTC detachment efficiency. Conclusions: It is feasible that the detachment efficiency can be further increased by a longer enzymatic incubation time or higher shear stress. The influence on the integrity and viability of cells must, however, be considered.
- Open Access
- 25 March 2025
- Published by Wiley in International Journal for Numerical Methods in Biomedical Engineering
- Vol. 41 (3) , e70032
Numerical Assessment of the Efficiency of a New Minimally Invasive Probe for the Isolation of Circulating Tumor Cells
Liquid biopsy, particularly the isolation of circulating tumor cells (CTCs) from blood, is a promising approach in the fight against cancer. However, the main reason why CTCs are hardly used as biomarkers in the clinic is their complicated isolation from the patient's blood. Existing ex vivo systems use a small volume of blood and can therefore only isolate very few CTCs. To overcome this problem and increase the number of isolated CTCs, a new in vivo method—the BMProbe was introduced, which can isolate CTCs directly from the patient's bloodstream. This study investigates the efficiency of the BMProbe by using Computational Fluid Dynamics simulations to evaluate parameters influencing the attachment probability of CTCs to the probe surface. The analyzed parameters include screened blood volume, residence time, and wall normal rate. Additionally, the impact of probe geometry, vein diameter, and blood flow velocity on probe efficiency was examined. The numerical data suggest that the geometry has a strong influence on cell binding efficiency. Increasing the number of windings from 4 to 32 improves the transport of cells to the surface (negative wall normal rate) from 0 to −29 [mm2/s] and the screened blood volume by 138% but decreases the residence time of particles in the close vicinity of the probe by 77%. When compared to experimental data, the screened blood volume and the wall normal rate indicate cell attachment very well, whereas the residence time does not show a significant impact on the attachment of cells. For the 32‐windings BMProbe, the screened blood volume is determined to be 130–313 mL, depending on the vein diameter, which is a multiple of the volume achieved by common CTC isolation techniques.
- 25 March 2025
- Published by Wiley in International Journal for Numerical Methods in Biomedical Engineering
- Vol. 41 (3) , e70032
Open AccessNumerical Assessment of the Efficiency of a New Minimally Invasive Probe for the Isolation of Circulating Tumor Cells
Liquid biopsy, particularly the isolation of circulating tumor cells (CTCs) from blood, is a promising approach in the fight against cancer. However, the main reason why CTCs are hardly used as biomarkers in the clinic is their complicated isolation from the patient's blood. Existing ex vivo systems use a small volume of blood and can therefore only isolate very few CTCs. To overcome this problem and increase the number of isolated CTCs, a new in vivo method—the BMProbe was introduced, which can isolate CTCs directly from the patient's bloodstream. This study investigates the efficiency of the BMProbe by using Computational Fluid Dynamics simulations to evaluate parameters influencing the attachment probability of CTCs to the probe surface. The analyzed parameters include screened blood volume, residence time, and wall normal rate. Additionally, the impact of probe geometry, vein diameter, and blood flow velocity on probe efficiency was examined. The numerical data suggest that the geometry has a strong influence on cell binding efficiency. Increasing the number of windings from 4 to 32 improves the transport of cells to the surface (negative wall normal rate) from 0 to −29 [mm2/s] and the screened blood volume by 138% but decreases the residence time of particles in the close vicinity of the probe by 77%. When compared to experimental data, the screened blood volume and the wall normal rate indicate cell attachment very well, whereas the residence time does not show a significant impact on the attachment of cells. For the 32‐windings BMProbe, the screened blood volume is determined to be 130–313 mL, depending on the vein diameter, which is a multiple of the volume achieved by common CTC isolation techniques.
- Open Access
- 27 June 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (13) , 5601
Experimental Device to Evaluate Aerosol Dispersion in Venues
The COVID-19 pandemic has focused attention on the importance of understanding and mitigating the airborne transmission of pathogens in indoor environments. This study investigated the aerosol distribution in different indoor venues with varying ventilation concepts, including displacement, mixed, and natural ventilation. A measurement system was developed to investigate venue-specific aerosol distribution patterns using a sodium chloride solution as a tracer. To analyse the spatial dispersion of aerosols, Computational Fluid Dynamics (CFD) simulations were conducted in addition to experimental investigations. The investigations indicated the lowest aerosol load for the venue with displacement ventilation and the highest for the naturally ventilated venue. The measurement system developed in this study provides a useful tool for assessing the effectiveness of ventilation measures in reducing airborne transmission of pathogens in indoor environments. It also proved its wide range of applications, as it can be used in variously sized and shaped indoor environments, with or without an audience.
- 27 June 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (13) , 5601
Open AccessExperimental Device to Evaluate Aerosol Dispersion in Venues
The COVID-19 pandemic has focused attention on the importance of understanding and mitigating the airborne transmission of pathogens in indoor environments. This study investigated the aerosol distribution in different indoor venues with varying ventilation concepts, including displacement, mixed, and natural ventilation. A measurement system was developed to investigate venue-specific aerosol distribution patterns using a sodium chloride solution as a tracer. To analyse the spatial dispersion of aerosols, Computational Fluid Dynamics (CFD) simulations were conducted in addition to experimental investigations. The investigations indicated the lowest aerosol load for the venue with displacement ventilation and the highest for the naturally ventilated venue. The measurement system developed in this study provides a useful tool for assessing the effectiveness of ventilation measures in reducing airborne transmission of pathogens in indoor environments. It also proved its wide range of applications, as it can be used in variously sized and shaped indoor environments, with or without an audience.
- Open Access
Experimental Device to Evaluate Aerosol Dispersion in Venues
The COVID-19 pandemic has focused attention to the importance of understanding and mitigating the airborne transmission of pathogens in indoor environments. This study investigated the aerosol distribution in different indoor venues with varying ventilation concepts, including displacement, mixed, and natural ventilation. A measurement system was developed to investigate venue-specific aerosol distribution patterns using a sodium chloride solution as a tracer. To analyse the spatial dispersion of aerosols, Computational Fluid Dynamics (CFD) simulations were conducted in addition to experimental investigations. The investigations indicated the lowest aerosol load for the venue with displacement ventilation and the highest for the natural ventilated venue. The measurement system developed in this study provides a useful tool for assessing the effectiveness of ventilation measures in reducing airborne transmission of pathogens in indoor environments. It also proved its wide range of applications, as it can be used in various sized and shaped indoor environments, with or without an audience.
Open AccessExperimental Device to Evaluate Aerosol Dispersion in Venues
The COVID-19 pandemic has focused attention to the importance of understanding and mitigating the airborne transmission of pathogens in indoor environments. This study investigated the aerosol distribution in different indoor venues with varying ventilation concepts, including displacement, mixed, and natural ventilation. A measurement system was developed to investigate venue-specific aerosol distribution patterns using a sodium chloride solution as a tracer. To analyse the spatial dispersion of aerosols, Computational Fluid Dynamics (CFD) simulations were conducted in addition to experimental investigations. The investigations indicated the lowest aerosol load for the venue with displacement ventilation and the highest for the natural ventilated venue. The measurement system developed in this study provides a useful tool for assessing the effectiveness of ventilation measures in reducing airborne transmission of pathogens in indoor environments. It also proved its wide range of applications, as it can be used in various sized and shaped indoor environments, with or without an audience.
- Open Access
Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients’ Blood
Circulating tumor cells (CTCs) exist in low quantities in the bloodstream in the early stages of cancers. It, therefore, remains a technical challenge to isolate them in large enough quantities for a precise diagnosis and downstream analysis. We introduce the BMProbe™, a minimally invasive device that isolates CTCs during a 30-minute incubation in the median cubital vein. The optimized geometry of the device creates flow conditions for improved cell deposition. The CTCs are isolated using antibodies that are bound to the surface of the BMProbe™. In this study, flow experiments using cell culture cells were conducted. They indicate a 31 times greater cell binding efficiency of the BMProbe™ compared to a flat geometry. Further, the functionality of isolating CTCs from patient blood was verified in a small ex vivo study that compared the cell count from seven non-small-cell lung carcinoma (NSCLC) patients compared to nine healthy controls with 10 mL blood samples. The median cell count was 1 in NSCLC patients and 0 in healthy controls. In conclusion, the BMProbe™ is a promising method to isolate CTCs in large quantities directly from the venous bloodstream without removing blood from a patient. The future step is to verify the functionality in vivo.
Open AccessVerification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients’ Blood
Circulating tumor cells (CTCs) exist in low quantities in the bloodstream in the early stages of cancers. It, therefore, remains a technical challenge to isolate them in large enough quantities for a precise diagnosis and downstream analysis. We introduce the BMProbe™, a minimally invasive device that isolates CTCs during a 30-minute incubation in the median cubital vein. The optimized geometry of the device creates flow conditions for improved cell deposition. The CTCs are isolated using antibodies that are bound to the surface of the BMProbe™. In this study, flow experiments using cell culture cells were conducted. They indicate a 31 times greater cell binding efficiency of the BMProbe™ compared to a flat geometry. Further, the functionality of isolating CTCs from patient blood was verified in a small ex vivo study that compared the cell count from seven non-small-cell lung carcinoma (NSCLC) patients compared to nine healthy controls with 10 mL blood samples. The median cell count was 1 in NSCLC patients and 0 in healthy controls. In conclusion, the BMProbe™ is a promising method to isolate CTCs in large quantities directly from the venous bloodstream without removing blood from a patient. The future step is to verify the functionality in vivo.
- Open Access
- 8 December 2021
- Published by Wiley in Advanced Engineering Materials
- Vol. 24 (7)
Investigation of the Attachment of Circulating Endothelial Cells to a Cell Probe: Combined Experimental and Numerical Study
- 8 December 2021
- Published by Wiley in Advanced Engineering Materials
- Vol. 24 (7)
Open AccessInvestigation of the Attachment of Circulating Endothelial Cells to a Cell Probe: Combined Experimental and Numerical Study